Krystal Biotech (KRYS) Times Interest Earned (2021)

Krystal Biotech's (KRYS) quarterly Times Interest Earned came in at -$9.62 in Q1 2021.

Krystal Biotech (KRYS) Times Interest Earned (2021) Analysis & Trends

Krystal Biotech has disclosed Times Interest Earned across 1 years of filings, most recently posting -$9.62 for Q1 2021.

  • Times Interest Earned for Q1 2021 came in at -$9.62, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was -$45.76 (changed N/A YoY), and the FY2021 annual result was -$45.76, changed N/A from the prior year.
  • Times Interest Earned came in at -$9.62 for Q1 2021 at Krystal Biotech.
  • In the past five years, Times Interest Earned ranged from a high of -$9.62 in Q1 2021 to a low of -$9.62 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 3.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 11.50
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -258.33
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 547.67
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 11.79
10 Krystal Biotech 10.23 Bn 9.41 Bn 110.03 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 -9.62